Page 144 - 南京医科大学学报自然科学版

第41卷第9期
·1410 · 南 京 医 科 大 学 学 报 2021年9月

21110 of the condition［J］. Parkinson’s Dis，2017，2017：1-18
［20］ LEE J Y，YOON E J，LEE W W，et al. Lateral geniculate ［33］ DAVE S，WEINTRAUB D，AARSLAND D，et al. Drug
atrophy in Parkinson’s with visual hallucination：a trans⁃ and disease effects in Parkinson’s psychosis：revisiting
synaptic degeneration?［J］. Mov Disord，2016，31（4）： the role of dopamine［J］. Mov Disord Clin Pract，2020，
547-554 7（1）：32-36
［21］ ORTUÑO⁃LIZARÁN I，SÁNCHEZ⁃SÁEZ X，LAX P，et ［34］ DAVE S，WEINTRAUB D，AARSLAND D，et al. Drug
al. Dopaminergic retinal cell loss and visual dysfunction and disease effects in Parkinson’s psychosis：revisiting
in parkinson disease［J］. Ann Neurol，2020，88（5）：893-906 the role of dopamine［J］. Mov Disord Clin Pract，2020，
［22］ CHANG A，FOX S H. Psychosis in Parkinson’s disease： 7（1）：32-36
epidemiology，pathophysiology，and management ［J］. ［35］DAFSARI H S，MARTINEZ⁃MARTIN P，RIZOS A，et al.
Drugs，2016，76（11）：1093-1118 EuroInf 2：subthalamic stimulation，apomorphine，and le⁃
［23］ NISHIO Y，YOKOI K，HIRAYAMA K，et al. Defining vi⁃ vodopa infusion in parkinson’s disease［J］. Mov Disord，
sual illusions in Parkinson’s disease：Kinetopsia and ob⁃ 2019，34（3）：353-365
ject misidentification illusions［J］. Parkinsonism Relat ［36］ LENKA A，HEGDE S，JHUNJHUNWALA K R，et al. In⁃
Disord，2018，55：111-116 teractions of visual hallucinations，rapid eye movement
［24］ PRELL T. Structural and functional brain patterns of non⁃ sleep behavior disorder and cognitive impairment in Par⁃
motor syndromes in parkinson’s disease［J］. Front Neu⁃ kinson’s disease：a review［J］. Parkinsonism Relat Dis⁃
rol，2018，9：138 ord，2016，22：1-8
［25］ ALIPOUR A，MOZHDEHFARAHBAKHSH A，NOURI S， ［37］ FACTOR S A，WM M，GOLDSTEIN F C. The role of neu⁃
et al. Studies on the bottom⁃up and top⁃down neural infor⁃ rotransmitters in the development of Parkinson’s disease⁃
mation flow alterations in neurodegeneration［J］. J Al⁃ related psychosis［J］. Eur J Neurol，2017，24（10）：1244-
zheimers Dis，2020，78（1）：169-183 1254
［26］ ONOFRJ M，ESPAY A J，BONANNI L，et al. Hallucina⁃ ［38］RUSSO M，CARRARINI C，DONO F，et al. The pharma⁃
tions，somatic⁃functional disorders of PD⁃DLB as expres⁃ cology of visual hallucinations in synucleinopathies［J］.
sions of thalamic dysfunction［J］. Mov Disord，2019，34 Front Pharmacol，2019，10：1379
（8）：1100-1111 ［39］ STAHL S M. Parkinson’s disease psychosis as a serotonin⁃
［27］ DAUWAN M，HOFF J I，VRIENS E M，et al. Aberrant dopamine imbalance syndrome［J］. CNS Spectr，2016，
resting⁃state oscillatory brain activity in Parkinson’s dis⁃ 21（5）：355-359
ease patients with visual hallucinations：An MEG source⁃ ［40］ SOMAN S，BHATTACHARYA A，PANICKER M M. Do⁃
space study［J］. Neuroimage Clin，2019，22：101752 pamine requires unique residues to signal via the sero⁃
［28］ SHINE J M，MULLER A J，O’CALLAGHAN C，et al. Ab⁃ tonin 2A receptor［J］. Neuroscience，2020，439：319-331
normal connectivity between the default mode and the ［41］ PAGANO G，POLITIS M. Molecular imaging of the seroto⁃
visual system underlies the manifestation of visual halluci⁃ nergic system in Parkinson’s disease［J］. Int Rev Neuro⁃
nations in Parkinson’s disease：a task⁃based fMRI study biol，2018，141：173-210
［J］. NPJ Parkinsons Dis，2015，1：15003 ［42］ SAHLI Z T，TARAZI F I. Pimavanserin：novel pharmaco⁃
［29］ HEPP D H，FONCKE E，OLDE D K，et al. Loss of func⁃ therapy for Parkinson’s disease psychosis［J］. Expert
tional connectivity in patients with Parkinson disease and Opin Drug Discov，2018，13（1）：103-110
visualhallucinations［J］. Radiology，2017，285（3）：896-903 ［43］ SCHMITZ T W，CORREIA M M，FERREIRA C S，et al.
［30］ WATANABE H，SENDA J，KATO S，et al. Cortical and Hippocampal GABA enables inhibitory control over un⁃
subcortical brain atrophy in Parkinson’s disease with wanted thoughts［J］. Nat Commun，2017，8（1）：1311
visual hallucination［J］. Mov Disord，2013，28（12）： ［44］ KHUNDAKAR A A，HANSON P S，ERSKINE D，et al.
1732-1736 Analysis of primary visual cortex in dementia with Lewy
［31］ CAI Y，FORD C P. Dopamine cells differentially regulate bodies indicates GABAergic involvement associated with
striatal cholinergic transmission across regions through recurrent complex visual hallucinations［J］. Acta Neuro⁃
corelease of dopamine and glutamate［J］. Cell Rep，2018， pathol Commun，2016，4（1）：66
25（11）：3148-3157.e3 ［45］ FIRBANK M J，PARIKH J，MURPHY N，et al. Reduced
［32］ TADDEI R N，CANKAYA S，DHALIWAL S，et al. Man⁃ occipital GABA in Parkinson disease with visual halluci⁃
agement of psychosis in Parkinson’s disease：emphasiz⁃ nations［J］. Neurology，2018，91（7）：e675-e685
ing clinical subtypes and pathophysiological mechanisms ［收稿日期］ 2021-04-21